Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GMVDF
G Medical Innovations
$0.00
$0.00
$0.02
$26K39.369,726 shsN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
$5.76
+3.8%
$28.44
$5.37
$1,200.00
$80K0.731.01 million shs56,548 shs
SDCCQ
SmileDirectClub
$0.00
$0.00
$0.01
$40K1.570,663 shsN/A
VRAYQ
ViewRay
$0.00
$0.00
$0.00
$18K1.05600 shs12,082 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GMVDF
G Medical Innovations
0.00%0.00%0.00%-50.00%-98.33%
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
+3.78%-16.64%-35.35%-97.26%-98.92%
SDCCQ
SmileDirectClub
0.00%0.00%0.00%0.00%-95.83%
VRAYQ
ViewRay
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
GMVDF
G Medical Innovations
N/AN/AN/AN/AN/AN/AN/AN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
0.2765 of 5 stars
0.02.00.00.01.10.80.6
SDCCQ
SmileDirectClub
N/AN/AN/AN/AN/AN/AN/AN/A
VRAYQ
ViewRay
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GMVDF
G Medical Innovations
0.00
N/AN/AN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
2.00
HoldN/AN/A
SDCCQ
SmileDirectClub
0.00
N/AN/AN/A
VRAYQ
ViewRay
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GMVDF
G Medical Innovations
$4.42M0.00N/AN/AN/ANaN
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
$520K0.11N/AN/A$212.95 per share0.03
SDCCQ
SmileDirectClub
$470.74M0.00N/AN/AN/ANaN
VRAYQ
ViewRay
$102.21M0.00N/AN/AN/ANaN
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GMVDF
G Medical Innovations
-$24.63MN/A0.00N/AN/AN/AN/AN/AN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
-$11.74M-$2,376.31N/AN/A-3,010.14%-418.82%-243.54%8/11/2025 (Estimated)
SDCCQ
SmileDirectClub
-$86.40MN/A0.00N/AN/AN/AN/AN/AN/A
VRAYQ
ViewRay
-$107.33MN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
GMVDF
G Medical Innovations
N/AN/AN/AN/AN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
N/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
N/AN/AN/AN/AN/A
VRAYQ
ViewRay
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GMVDF
G Medical Innovations
N/AN/AN/A
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
N/A
1.69
1.13
SDCCQ
SmileDirectClub
N/AN/AN/A
VRAYQ
ViewRay
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
GMVDF
G Medical Innovations
5.96%
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
18.63%
SDCCQ
SmileDirectClub
0.07%
VRAYQ
ViewRay
15.47%

Insider Ownership

CompanyInsider Ownership
GMVDF
G Medical Innovations
37.10%
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
17.90%
SDCCQ
SmileDirectClub
64.70%
VRAYQ
ViewRay
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
GMVDF
G Medical Innovations
72259.92 million163.49 millionNot Optionable
Helius Medical Technologies, Inc. stock logo
HSDT
Helius Medical Technologies
3010,00011,000Not Optionable
SDCCQ
SmileDirectClub
2,700402.61 million142.12 millionOptionable
VRAYQ
ViewRay
300183.40 million178.82 millionNo Data

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

G Medical Innovations NASDAQ:GMVDF

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.

Helius Medical Technologies stock logo

Helius Medical Technologies NASDAQ:HSDT

$5.76 +0.21 (+3.78%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$5.76 +0.00 (+0.09%)
As of 04:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.

SmileDirectClub NASDAQ:SDCCQ

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee. On January 26, 2024, the voluntary petition of SmileDirectClub, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 29, 2023..

ViewRay NASDAQ:VRAYQ

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado. On July 16, 2023, ViewRay, Inc., alongwith its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay , Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.